CHARLES RIVER LABORATORIES INTERNATIONAL, INC.— Sankey Diagram
Annual mode · period ending 2025-12-27 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$7.14B
↓-5.2% -$393Mvs FY2024
Total Liabilities
$3.92B
↓-2.4% -$96Mvs FY2024
Equity
$3.16B
↓-8.6% -$297Mvs FY2024
Cash
$214M
↑+9.8% +$19Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $7.14B | $7.53B |
| Current Assets | $1.45B | $1.40B |
| Cash | $214M | $195M |
| ST Investments | $0 | $0 |
| Receivables | $709M | $721M |
| Inventory | $299M | $279M |
| Other Current | $225M | $209M |
| Non-Current Assets | $5.69B | $6.13B |
| PPE | $1.66B | $1.60B |
| Goodwill | $2.76B | $2.85B |
| Intangibles | $340M | $723M |
| Investments | $0 | $0 |
| Other Non-Current | $929M | $951M |
| Total Liab+Eq | $7.09B | $7.48B |
| Current Liab. | $1.12B | $994M |
| Accounts Payable | $149M | $140M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $210M | $248M |
| Other CL | $761M | $605M |
| Non-Current Liab. | $2.80B | $3.03B |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $2.80B | $3.03B |
| Equity | $3.16B | $3.46B |
| Retained Earnings | $1.39B | $1.81B |
| Other Equity | $1.78B | $1.65B |
QuarterCharts · SEC EDGAR data · CRL · Comparing FY2025 vs FY2024